Recent Articles from TheStreet

Clorox Lead

Clorox Stock Sinks as Easing Pandemic Fears Put Dent in Sales

Clorox shares drop after the company misses fourth-quarter expectations and provides weak guidance.

What Under Armour's CEO Told Jim Cramer

Premarket Movers Tuesday: Under Armour, Alibaba, Clorox

Stocks moving in premarket trading Tuesday include Under Armour, Alibaba, Clorox, Take-Two and Translate Bio.

Take-Two To Discuss Third-Quarter Results, Social Point Acquisition

Take-Two Stock Tumbles, Leading Video Game Companies Lower, On China Crackdown

China's state-backed Economic Information Daily newspaper described online gaming as "spiritual opium", and called for stricter curbs on $55 billion sector.

emergency ambulance deaths sh

New Law Will Protect Patients From Surprise Medical Bills

The No Surprises Act will help  counteract a growing burden of excessive healthcare charges.

Learn the possible impacts on your taxes of an early withdrawal from your 401(k).

How to Pay Your Taxes: 10 Ways to Pay Your Tax Bill

You know you owe taxes, but you may not be aware of all the available options for getting that money to the IRS.

Under Armour Lead

Under Armour Stock Surges on Earnings Beat, 2021 Sales Forecast Boost

'Given the continued momentum, we're raising our full-year outlook, which puts us on track to achieving a solid performance in 2021,' says CEO Patrik Frisk.

alibaba zhu difeng : Shutterstock

Alibaba Stock Falls After Earnings Beat as Beijing Crackdown Reports Rattle China Markets

'We believe in the growth of the Chinese economy and long-term value creation of Alibaba,' says CEO David Zhang.

Jim Cramer: Pepsi Probiotic Purchase Won't Pop Stock

PepsiCo to Sell Tropicana and Other Juice Brands to Private-Equity Firm for $3.3 Billion

PepsiCo agrees to sell its Tropicana, Naked and other juice brands to private-equity firm PAI Partners in a $3.3 billion after-tax all-cash deal.

Pfizer Covid-19 Vaccine Lead

Translate Bio Stock Jumps as Sanofi to Buy U.S. Partner for $3.2 Billion

Translate Bio stock surges after Sanofi agrees to buy its messenger-RNA development partner for $3.2 billion in a bid to catch up in the COVID vaccine race.

Eli Lilly Lead

Eli Lilly Stock Slides on Earnings Miss, Outlook Change; Trulicity Sales Impress

Eli Lilly trims its reported profit forecast for the full-year 2021 year after weaker-than-expected June quarter earnings.